TRIAL MANAGEMENT
Cognitive, Pharmacodynamic Testing During FIH CNS Trials
A comprehensive review of optimal timing and methodologies for cognitive and pharmacodynamic testing during first-in-human trials on CNS-active compounds.
Driving Simulation Studies At Altasciences
At Altasciences, we design driving studies to achieve your objectives, leveraging extensive experience across clinical testing of cognitive effects.
Think U.S.A.: The Operations Behind Your Clinical Trials
Ready to think differently about early-phase clinical development? Check out the spotlight on our U.S. clinical facilities and the incredible teams behind them.
The New Era Of Project Optimus: Implications For Oncology Development Strategy
In this presentation, expert speakers bring the impact of Project Optimus to life through real-world case studies and practical examples.
Are Your Clinical Study Meetings Building Momentum, Or Wasting Time?
Transforming passive clinical trial meetings into active catalysts for success, aligning teams and accelerating timelines.
TMF Management In Clinical Trials
Elevate your knowledge of clinical trials and the Trial Master File by exploring three critical topics.
Webinar: Reimbursement Methods For Sustainable CGT Business Models
Learn more about the key features of successful innovative pricing and reimbursement models as well as outcomes-based agreements and the ways to advance those strategies for cell and gene therapies.
Digital Physical Activity Measures In Phase 3 Immunology Trials
Dr. Jie Shen, Research Fellow and Director of Digital Science at AbbVie, shares lessons learned from incorporating digital measures of physical activity into Phase 3 immunology clinical trials.
How RWD Reshapes Patient Recruitment Strategies
Discover how real-world data (RWD) is transforming patient recruitment by shifting from traditional site-centered methods to a patient-first approach.
Clinical Trials And TMF 101 Learning Series: 1st Session
Spark a deeper and broader understanding of the world of Drug Development, Clinical Trials, Regulations, the Trial Master File, and much more – for the industry novice as well as the guru.
How To Boost Disclosure Efficiencies With Outsourcing
In this webinar, you’ll hear about exciting new advisory and managed disclosure services from TrialScope, including: compliance, policy and process assessments, as well as plain-language summaries, protocol registration, results posting, and redaction services.
...
Navigating Early Phase CNS-Active Drug Development
Early development of CNS-active drugs requires in-depth clinical expertise. Altasciences’ Dr. Beatrice Setnik, Chief Scientific Officer, examines the strategies to ensure early comprehensive data collection to fulfill regulatory requirements and aid in evaluating th...
Yes, Your Study Is At Risk: Risk Mitigation Plans For Endpoints
Ocular endpoints often introduce unique bottlenecks that can stall enrollment and compromise data integrity. This presentation provides the tools for a streamlined, resilient clinical trial strategy.
Clinical Research Without Borders
Explore strategies for navigating global clinical trials with, Afshawn Chakamian of Avidity Biosciences, Dr. Amy Raymond of Worldwide Clinical Trials, Scott Schliebner of Novotech, and Scout’s KimberLee Heidmann.
Disclosure As A Service ROI
How do sponsors determine the ROI of Disclosure as a Service? TrialScope talks with two sponsors – a large pharmaceutical company and a smaller biotech – for their take on this. Watch the short video.
CTIS Master Series 1: Are You Ready For CTIS?
In this informative webinar, clinical trial disclosure experts Francine Lane and Thomas Wicks provide a high-level overview of EU CTR/CTIS regulations, show how they differ from the EU CTD directive, share timelines for compliance, and discuss the scope of data sharing.
Illuminating IHC: From Biomarker To Clinical Trial Assay
Through this presentation, Immunohistochemistry (IHC) expert equip you with the knowledge needed to effectively utilize IHC in your research and clinical practice.
Strategic Considerations For A Successful CNS Clinical Development Pathway
Dr. Beatrice Setnik, Chief Scientific Officer at Altasciences, discusses tactics for a successful clinical development pathway for CNS-active drugs.
Accelerate Your Data With Our Co-Located Clinic And Lab
Watch as we take your fresh sample from our clinic to PBMC separation. This video overviews our optimized workflows that ensure timely processing, transport, and analysis of your samples.
What Is The Secret To Ongoing TMF Health?
Delve into specific tactics clinical teams can utilize for establishing immediate and long-lasting improvements to their TMF business processes.
Why Disclosure As A Service?
Two clinical trial sponsors – one larger pharmaceutical company and one smaller biotech – share with TrialScope what their main reasons were for initially considering Disclosure as a Service. Watch the short video.
Clinical Trials And TMF 101 Learning Series: 2nd Session
The “Clinical Trials and TMF 101 Learning Series” kicks off it’s second session with three industry experts, that goes through some of the basics of clinical trials.
CAR-T Cell Therapies: Advancements In Cancer Trials & Treatment
Watch as Managing Editor of Pharmaceutical Technology Jeanne Linke Northrop talks with Tanmay Jain, Sr. Director of Trial Design Solutions within Medidata AI, about the use of CAR-T cell therapies within the oncology space.
Why Disclosure Assessments Are The First Step To Improvement
Whether your organization lacks formal disclosure policies and procedures, or has longstanding SOPs in place, the best way to gauge the effectiveness of your clinical trial disclosure process is via a third-party assessment.
Exploring The Principles Integral To Rare Disease Drug Development
This on-demand webinar offers valuable insights into successful rare disease drug development, including study design, regulatory engagement, and market access strategy.
The Golden Era Of GLP-1 Drugs
As GLP-1 drugs reshape the market, understanding their potential risks, applications, and economic effects is crucial for professionals in the pharmaceutical and healthcare industries.
Sponsors' Advice On Disclosure As A Service
Representatives from Teva and Lung Biotechnology share their insights for other sponsors considering Disclosure as a Service. Watch the short video now.
Secrets To A Collaborative Model To Improve TMF Management
Speakers from Phlexglobal and Regeneron share the benefits of their highly effective partnering model and lessons learned that you can apply in your organization.
Tackling The EU CTR Compliance Challenge
Maintaining disclosure compliance is tricky enough with ClinicalTrials.gov, but when it comes to EU CTR compliance, the complexity rises to a whole new level. As a sponsor, do you find your organization “guilty” of these common errors?
At The Crossroads Of Data: eCOA And Sensors Converging For Novel Insights
Leveraging sensors and eCOA addresses increasing clinical trial complexity and ensures a more efficient and effective study design.
